| Autor: |
Bidault, G, Virtue, S, Petkevicius, K, Jolin, HE, Dugourd, A, Guenantin, AC, Leggat, J, Mahler-Araujo, B, Lam, BYH, Ma, MK, Dale, M, Carobbio, S, Kaser, A, Fallon, PG, Saez Rodriguez, J, McKenzie, ANJ, Vidal-Puig, A |
| Přispěvatelé: |
Bidault, Guillaume [0000-0002-8396-9962], Vidal-Puig, Antonio [0000-0003-4220-9577], Apollo - University of Cambridge Repository |
| Rok vydání: |
2021 |
| Předmět: |
|
| DOI: |
10.17863/cam.77051 |
| Popis: |
Macrophages exhibit a spectrum of activation states ranging from classical to alternative activation1. Alternatively, activated macrophages are involved in diverse pathophysiological processes such as confining tissue parasites2, improving insulin sensitivity3 or promoting an immune tolerant microenvironment that facilitates tumour growth and metastasis4. Recently, the role of metabolism regulating macrophage function has come into focus as both the classical and alternative activation programmes require specific regulated metabolic reprogramming5. While most of the studies regarding immunometabolism have focussed on the catabolic pathways activated to provide energy, little is known about the anabolic pathways mediating macrophage alternative activation. In this study, we show that the anabolic transcription factor sterol regulatory element binding protein 1 (SREBP1) is activated in response to the canonical Th2 cytokine interleukin 4 (IL-4) to trigger the de novo lipogenesis (DNL) programme, as a necessary step for macrophage alternative activation. Mechanistically, DNL consumes NADPH, partitioning it away from cellular antioxidant defences and raising ROS levels. ROS serves as a second messenger, signalling sufficient DNL, and promoting macrophage alternative activation. The pathophysiological relevance of this mechanism is validated by showing that SREBP1/DNL is essential for macrophage alternative activation in vivo in a helminth infection model. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
